IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 78 filers reported holding IMMUNOMEDICS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $91,498,000 | +213.8% | 1,076,061 | +30.8% | 0.01% | +200.0% |
Q2 2020 | $29,155,000 | +221.2% | 822,665 | +22.2% | 0.00% | +100.0% |
Q1 2020 | $9,078,000 | -48.7% | 673,479 | -19.5% | 0.00% | -33.3% |
Q4 2019 | $17,699,000 | +96.4% | 836,445 | +23.1% | 0.00% | +200.0% |
Q3 2019 | $9,010,000 | -11.3% | 679,498 | -7.2% | 0.00% | -50.0% |
Q2 2019 | $10,155,000 | -60.9% | 732,135 | -45.9% | 0.00% | -50.0% |
Q1 2019 | $25,973,000 | +55.2% | 1,352,085 | +15.3% | 0.00% | +33.3% |
Q4 2018 | $16,732,000 | +340.9% | 1,172,541 | +543.7% | 0.00% | – |
Q3 2018 | $3,795,000 | -33.5% | 182,147 | -24.4% | 0.00% | -100.0% |
Q2 2018 | $5,703,000 | -74.3% | 240,947 | -84.1% | 0.00% | -66.7% |
Q1 2018 | $22,170,000 | -3.4% | 1,517,428 | +6.8% | 0.00% | -25.0% |
Q4 2017 | $22,952,000 | +2360.0% | 1,420,239 | +2028.3% | 0.00% | – |
Q3 2017 | $933,000 | +219.5% | 66,732 | +101.6% | 0.00% | – |
Q2 2017 | $292,000 | +33.9% | 33,102 | -1.8% | 0.00% | – |
Q1 2017 | $218,000 | +26.0% | 33,707 | -28.7% | 0.00% | – |
Q4 2016 | $173,000 | +293.2% | 47,281 | +252.7% | 0.00% | – |
Q3 2016 | $44,000 | -8.3% | 13,404 | -34.3% | 0.00% | – |
Q2 2016 | $48,000 | +71.4% | 20,396 | +83.7% | 0.00% | – |
Q1 2016 | $28,000 | -66.7% | 11,100 | -59.5% | 0.00% | – |
Q4 2015 | $84,000 | +1100.0% | 27,375 | +571.3% | 0.00% | – |
Q3 2015 | $7,000 | -89.1% | 4,078 | -74.2% | 0.00% | – |
Q2 2015 | $64,000 | +357.1% | 15,816 | +339.3% | 0.00% | – |
Q1 2015 | $14,000 | -46.2% | 3,600 | -32.7% | 0.00% | – |
Q4 2014 | $26,000 | -48.0% | 5,350 | -60.3% | 0.00% | – |
Q3 2014 | $50,000 | +92.3% | 13,487 | +91.0% | 0.00% | – |
Q2 2014 | $26,000 | +4.0% | 7,063 | +20.5% | 0.00% | – |
Q1 2014 | $25,000 | -72.8% | 5,863 | -70.7% | 0.00% | – |
Q4 2013 | $92,000 | +196.8% | 20,000 | +298.0% | 0.00% | – |
Q3 2013 | $31,000 | -42.6% | 5,025 | -49.5% | 0.00% | – |
Q2 2013 | $54,000 | – | 9,947 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |